Madrigal Pharmaceuticals
MDGL
#2306
Rank
โ‚ฌ6.21 B
Marketcap
285,03ย โ‚ฌ
Share price
7.64%
Change (1 day)
38.37%
Change (1 year)

EPS for Madrigal Pharmaceuticals (MDGL)

EPS in 2023 (TTM): -17,67ย โ‚ฌ

According to Madrigal Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -18,10ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -16,72ย โ‚ฌ a decrease over its 2021 EPS that were of -14,18ย โ‚ฌ.

EPS history for Madrigal Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-17,67ย โ‚ฌ5.65%
2022-16,72ย โ‚ฌ17.93%
2021-14,18ย โ‚ฌ11.61%
2020-12,71ย โ‚ฌ140.18%
2019-5,29ย โ‚ฌ146.61%
2018-2,15ย โ‚ฌ-12.99%
2017-2,47ย โ‚ฌ-91.03%
2016-27,48ย โ‚ฌ-14.83%
2015-32,27ย โ‚ฌ6.71%
2014-30,24ย โ‚ฌ-29.92%
2013-43,15ย โ‚ฌ19.81%
2012-36,01ย โ‚ฌ6%
2011-33,97ย โ‚ฌ7.53%
2010-31,60ย โ‚ฌ-139.74%
200979,50ย โ‚ฌ-185.4%
2008-93,09ย โ‚ฌ-31.67%
2007-136,24ย โ‚ฌ52.27%
2006-89,47ย โ‚ฌ-27.65%
2005-123,67ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-0,97ย โ‚ฌ-94.64%๐Ÿ‡บ๐Ÿ‡ธ USA
-0,26ย โ‚ฌ-98.55%๐Ÿ‡บ๐Ÿ‡ธ USA